---
title: "CytomX Therapeutics names Alejandra Carvajal chief legal officer"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294690041.md"
description: "CytomX Therapeutics has appointed Alejandra Carvajal as its new chief legal officer. In this role, she will support the company's strategic, operational, and pipeline initiatives. Carvajal brings extensive experience, having previously served as senior vice president and chief legal officer at Mersana Therapeutics, as well holding CLO roles at Momenta Pharmaceuticals, Cerulean Pharma, and Millennium Pharmaceuticals."
datetime: "2026-08-03T12:04:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294690041.md)
  - [en](https://longbridge.com/en/news/294690041.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294690041.md)
generator: "portal-rs"
---

# CytomX Therapeutics names Alejandra Carvajal chief legal officer

-   CytomX Therapeutics appointed Alejandra Carvajal as chief legal officer to support strategic, operational, and pipeline initiatives. \* Carvajal previously served as senior vice president, chief legal officer, secretary at Mersana Therapeutics. \* Earlier roles included chief legal officer at Momenta Pharmaceuticals, general counsel at Cerulean Pharma, legal leadership positions at Millennium Pharmaceuticals. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytomX Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608030800PRIMZONEFULLFEED9800333) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [CTMX.US](https://longbridge.com/en/quote/CTMX.US.md)
- [MRSN.US](https://longbridge.com/en/quote/MRSN.US.md)

## Related News & Research

- [CytomX Therapeutics to present at Wells Fargo Annual Healthcare Conference fireside chat](https://longbridge.com/en/news/297649740.md)
- [Pentwater Capital cuts Faron Pharmaceuticals stake below 3% via cash-settled swap](https://longbridge.com/en/news/298022326.md)
- [Grace Therapeutics CEO presents at H.C. Wainwright Global Investment Conference](https://longbridge.com/en/news/297910585.md)
- [Faron Pharmaceuticals Ltd: Holding(s) In Company](https://longbridge.com/en/news/298025632.md)
- [Is Vertex Pharmaceuticals (VRTX) Undervalued Following Casgevy’s FDA Label Expansion?](https://longbridge.com/en/news/297989826.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**